Eocene Ltd. (EOCN) vs Mustang Bio, Inc. (MBIO)
A side-by-side comparison of Eocene Ltd. and Mustang Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EOCN
Eocene Ltd.
$3.38HealthcareDelayed quote: Oct 6, 2026, 10:41 AM EDT
MBIO
Mustang Bio, Inc.
$0.46HealthcareDelayed quote: Oct 6, 2026, 10:49 AM EDT
Total return — EOCN vs MBIO
growth of $100 · dividends reinvested · last 1yEOCN -15.9% (-15.9%/yr)MBIO -22.5% (-22.5%/yr)EOCN compounded faster over this window
EOCN MBIO
Metrics side by side
Total return (annualized)
| Metric | EOCN | MBIO |
|---|---|---|
| Total return (1Y) | N/A | -70.71% |
| Total return CAGR (3Y) | N/A | -83.36% |
| Total return CAGR (5Y) | N/A | -80.80% |
EOCN is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.